It inhibits nicotinamide N-methyltransferase (NNMT), an enzyme that when overactive, consumes excessive NAD+ and impairs cellular energy metabolism
The 50 mg lyophilized vial format is intended for extended research protocols and bulk in vitro / preclinical assay use
INDICATION: Nutritional supplement for animals with anorexia, liver disorders, stunted growth and stress
It also helps to reduce the risk of developing heart attack, dementia, and stroke, since it decreases homocysteine levels
In scientific literature, NNMT is recognized as an enzyme that methylates nicotinamide (a precursor of NAD+) using S-adenosylmethionine (SAM) as the methyl donor, converting it to 1-methylnicotinamide (MNA) and potentially affecting cellular NAD+ availability